Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Stage III Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01986712
What this trial is testing

Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
St. Luke's Hospital and Health Network, Pennsylvania 50
Not applicableStudy completedNCT05079113
What this trial is testing

Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

Who this might be right for
Stage III MelanomaStage IV Cutaneous Melanoma
Case Comprehensive Cancer Center 73
Large-scale testing (Phase 3)Looking for participantsNCT06246149
What this trial is testing

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Who this might be right for
Uveal Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 290
Early research (Phase 1)Study completedNCT00003224
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Virginia 22
Testing effectiveness (Phase 2)Ended earlyNCT04455503
What this trial is testing

Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1

Who this might be right for
Melanoma Stage IVMelanoma Stage III
Evaxion Biotech A/S 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05270044
What this trial is testing

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

Who this might be right for
Melanoma
Pierre Fabre Medicament 815
Large-scale testing (Phase 3)UnknownNCT00226408
What this trial is testing

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Who this might be right for
AdjuvantStage III Malignant MelanomaInterferon Alpha+1 more
Dermatologic Cooperative Oncology Group 600
Large-scale testing (Phase 3)Ended earlyNCT01546571
What this trial is testing

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Who this might be right for
Melanoma
Polynoma LLC 504
Large-scale testing (Phase 3)Study completedNCT00006237
What this trial is testing

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 432
Not applicableStudy completedNCT01460875
What this trial is testing

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Who this might be right for
Stage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more
William Carson 34
Testing effectiveness (Phase 2)Study completedNCT02500576
What this trial is testing

Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more
M.D. Anderson Cancer Center 18
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Large-scale testing (Phase 3)Study completedNCT00002892
What this trial is testing

Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma

Who this might be right for
Melanoma (Skin)
Institute of Cancer Research, United Kingdom 1,000
Large-scale testing (Phase 3)Study completedNCT00636168
What this trial is testing

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

Who this might be right for
High Risk Stage III Melanoma
Bristol-Myers Squibb 1,211
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT00489944
What this trial is testing

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Who this might be right for
Intraocular Melanoma
San Diego Pacific Oncology & Hematology Associates 50
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Large-scale testing (Phase 3)Ended earlyNCT00036816
What this trial is testing

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 13
Large-scale testing (Phase 3)UnknownNCT03435302
What this trial is testing

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 204
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698019
What this trial is testing

Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

Who this might be right for
Acral Lentiginous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+1 more
National Cancer Institute (NCI) 313
Next Page